| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 1 | 02126 | 药明巨诺-B | SWCS Trust Limited |
减持 | -680.99万 | 0.00万 | 0.00% | 2023-06-07 |
| 2 | 02126 | 药明巨诺-B | SWCS Trust Limited |
增持 | 122.13万 | 680.99万 | 1.66% | 2023-01-26 |
| 3 | 02126 | 药明巨诺-B | SWCS Trust Limited |
增持 | 558.86万 | 558.86万 | 1.36% | 2022-04-11 |
| 4 | 02126 | 药明巨诺-B | Fullerton Management Pte Ltd |
减持 | -2266.87万 | 0.00万 | 0.00% | 2021-09-16 |
| 5 | 02126 | 药明巨诺-B | TLS Beta Pte. Ltd. |
减持 | -2266.87万 | 0.00万 | 0.00% | 2021-09-16 |
| 6 | 02126 | 药明巨诺-B | Temasek Life Sciences Private Limited |
减持 | -2266.87万 | 0.00万 | 0.00% | 2021-09-16 |
| 7 | 02126 | 药明巨诺-B | Temasek Holdings (Private) Limited |
减持 | -2429.67万 | 0.00万 | 0.00% | 2021-09-16 |
| 8 | 02126 | 药明巨诺-B | Morgan Stanley |
减持 | -2207.89万 | 396.84万 | 0.98% | 2021-09-16 |
| 9 | 02126 | 药明巨诺-B | Morgan Stanley |
增持 | 2413.13万 | 2593.57万 | 6.45% | 2021-09-14 |
| 10 | 02126 | 药明巨诺-B | Syracuse Biopharma (Cayman) Ltd. |
减持 | -4851.34万 | 0.00万 | 0.00% | 2021-08-27 |
| 11 | 02126 | 药明巨诺-B | Morgan Stanley |
减持 | -2094.28万 | 426.87万 | 1.06% | 2021-07-02 |
| 12 | 02126 | 药明巨诺-B | WuXi AppTec Co., Ltd. |
减持 | -2300.00万 | 1523.26万 | 3.80% | 2021-07-02 |
| 13 | 02126 | 药明巨诺-B | 上海药明康德新药开发有限公司 |
减持 | -2300.00万 | 1523.26万 | 3.80% | 2021-07-02 |
| 14 | 02126 | 药明巨诺-B | WuXi AppTec (Hong Kong) Holding Limited |
减持 | -2300.00万 | 1523.26万 | 3.80% | 2021-07-02 |
| 15 | 02126 | 药明巨诺-B | Morgan Stanley |
增持 | 2341.05万 | 2518.50万 | 6.28% | 2021-06-29 |
| 16 | 02126 | 药明巨诺-B | The Goldman Sachs Group, Inc. |
减持 | -18.65万 | 1870.20万 | 4.97% | 2020-11-23 |
| 17 | 02126 | 药明巨诺-B | The Goldman Sachs Group, Inc. |
增持 | 135.80万 | 1985.56万 | 5.28% | 2020-11-04 |
